Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

Ticagrelor with or without Aspirin in High-Risk Patients with Diabetes Mellitus undergoing Percutaneous Coronary Intervention

(2020) Dominick J. Angiolillo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y 12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial

(2019) Francesco Franchi et al.   Journal of the American Heart Association

Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases

(2019) Peter Bramlage et al.   Cardiovascular Diabetology

Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease

(2019) Ana Palanca et al.   Cardiovascular Diabetology

Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention

(2019) Joo-Yong Hahn et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

(2019) Hirotoshi Watanabe et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

(2019) Deepak L Bhatt et al.   LANCET

Ticagrelor with or without Aspirin in High-Risk Patients after PCI

(2019) Roxana Mehran et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ticagrelor in Patients with Stable Coronary Disease and Diabetes

(2019) P. Gabriel Steg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Standardized End Point Definitions for Coronary Intervention Trials

(2018) Hector M Garcia-Garcia et al.   EUROPEAN HEART JOURNAL

2018 ESC/EACTS Guidelines on myocardial revascularization

(2018) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

(2018) Pascal Vranckx et al.   LANCET

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials

(2017) Francesco Costa et al.   LANCET

Comparative efficacy of coronary artery bypass surgery vs. percutaneous coronary intervention in patients with diabetes and multivessel coronary artery disease with or without chronic kidney disease

(2016) Usman Baber et al.   EUROPEAN HEART JOURNAL

Reduction in Ischemic Events With Ticagrelor in Diabetic Patients With Prior Myocardial Infarction in PEGASUS–TIMI 54

(2016) Deepak L. Bhatt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents

(2016) Usman Baber et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial

(2016) Pascal Vranckx et al.   EuroIntervention

Defining the Link Between Chronic Kidney Disease, High Platelet Reactivity, and Clinical Outcomes in Clopidogrel-Treated Patients Undergoing Percutaneous Coronary Intervention

(2015) F. Franchi et al.   Circulation-Cardiovascular Interventions

CKD Prevalence Varies across the European General Population

(2015) K. Bru ck et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

(2015) Marc P. Bonaca et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and Incidence Trends for Diagnosed Diabetes Among Adults Aged 20 to 79 Years, United States, 1980-2012

(2014) Linda S. Geiss et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Antithrombotic Therapy in Patients With Chronic Kidney Disease

(2012) Davide Capodanno et al.   CIRCULATION

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

(2011) José Luis Ferreiro et al.   CIRCULATION

Standardized Bleeding Definitions for Cardiovascular Clinical Trials

(2011) Roxana Mehran et al.   CIRCULATION

Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function

(2010) Stefan James et al.   CIRCULATION